Anzeige
Mehr »
Login
Montag, 25.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
500% Potenzial: Warum Analysten von diesem Uran-Explorer begeistert sind!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QML9 | ISIN: KYG6082P1054 | Ticker-Symbol: 72X
Frankfurt
25.11.24
08:27 Uhr
0,072 Euro
+0,031
+74,39 %
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
MICROPORT CARDIOFLOW MEDTECH CORPORATION Chart 1 Jahr
5-Tage-Chart
MICROPORT CARDIOFLOW MEDTECH CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
0,0710,09514:07
0,0710,09514:08

Aktuelle News zur MICROPORT CARDIOFLOW MEDTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
30.09.CARDIOFLOW-B (02160): PROVISION OF GUARANTEES FOR MP CARDIOADVENT AND REVISION OF ANNUAL CAP FOR CONTINUING CONNECTED TRANSACTIONS UNDER THE 2023 MASTER ...-
26.09.CARDIOFLOW-B (02160): 2024 INTERIM REPORT-
20.09.CARDIOFLOW-B (02160): POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON SEPTEMBER 20, 2024-
29.08.CARDIOFLOW-B (02160): FORM OF PROXY FOR USE AT THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON FRIDAY, SEPTEMBER 20, 2024-
29.08.CARDIOFLOW-B (02160): NOTICE OF EXTRAORDINARY GENERAL MEETING1
29.08.CARDIOFLOW-B (02160): DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF THE ENTIRE EQUITY INTEREST OF THE TARGET COMPANY AND NOTICE ...-
28.08.CARDIOFLOW-B (02160): ANNOUNCEMENT OF UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 20241
22.08.CARDIOFLOW-B (02160): DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF THE ENTIRE EQUITY INTEREST OF THE TARGET COMPANY-
MICROPORT CARDIOFLOW MEDTECH Aktie jetzt für 0€ handeln
14.08.CARDIOFLOW-B (02160): DATE OF BOARD MEETING1
24.07.CARDIOFLOW-B (02160): PROFIT FORECAST FOR THE FIRST HALF OF 2024 - SIGNIFICANT REDUCTION IN NET LOSS OF APPROXIMATELY 63% TO 72%1
22.07.CARDIOFLOW-B (02160): LETTER TO NON-REGISTERED SHAREHOLDERS - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS1
22.07.CARDIOFLOW-B (02160): LETTER TO REGISTERED SHAREHOLDERS - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS1
19.07.CARDIOFLOW-B (02160): CONTINUING CONNECTED TRANSACTION IN RELATION TO THE 2024 KEWEI DISTRIBUTION FRAMEWORK AGREEMENT AND CONNECTED TRANSACTION IN RELATION ...1
04.07.CARDIOFLOW-B (02160): ESTIMATED INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2024 AND BUSINESS UPDATE-
26.06.CARDIOFLOW-B (02160): SIXTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION1
26.06.CARDIOFLOW-B (02160): POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 26, 2024-
17.06.CardioFlow wins CE mark for VitaFlow Liberty TAVI system1
17.06.MicroPort CardioFlow Medtech Corporation: CardioFlow's VitaFlow Liberty Granted EU CE-MDR Mark, Advancing Global Expansion Roadmap754SHANGHAI, June 17, 2024 /PRNewswire/ -- MicroPort® CardioFlow Medtech Corporation (CardioFlow) (Stock Code: 02160.HK) recently announced that its self-developed second-generation transcatheter...
► Artikel lesen
31.05.CARDIOFLOW-B (02160): FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, JUNE 26, 20241
31.05.CARDIOFLOW-B (02160): NOTICE OF ANNUAL GENERAL MEETING-
Seite:  Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1